Phase II study of the combination of bevacizumab plus irinotecan and temozolomide for relapsed or refractory neuroblastoma (NB) Meeting Abstract
| Authors: | Modak, S.; Kushner, B. H.; Kramer, K.; Leyco, S.; Basu, E. M.; Roberts, S. S.; Cheung, N. K. V. |
| Abstract Title: | Phase II study of the combination of bevacizumab plus irinotecan and temozolomide for relapsed or refractory neuroblastoma (NB) |
| Meeting Title: | 52nd Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 34 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2016 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2016-05-20 |
| Start Page: | 560s |
| Language: | English |
| ACCESSION: | WOS:000404712500348 |
| DOI: | 10.1200/JCO.2016.34.15_suppl.10554 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 10554 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
